One fi­nal push: EU phar­ma in­dus­try group de­mands com­pe­ti­tion check on in­com­ing leg­isla­tive over­haul

The Brus­sels-based Eu­ro­pean Fed­er­a­tion of Phar­ma­ceu­ti­cal In­dus­tries and As­so­ci­a­tions (EF­PIA) this morn­ing called on the Eu­ro­pean Com­mis­sion to en­sure that it ad­e­quate­ly as­sess­es how its re-writ­ing of the 20+-year-old phar­ma leg­is­la­tion, which is due to be re­leased be­fore the end of the month, dam­ages the com­pet­i­tive­ness of the phar­ma in­dus­try.

EF­PIA’s op­po­si­tion to the changes has lin­gered since the be­gin­ning, and its lat­est es­ti­mate is that the rewrit­ten leg­is­la­tion could cost the in­dus­try €640 mil­lion ($688 mil­lion).

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER